Glutamate (Metabotropic) Group III Receptor Modulators
| Cat. No. | Product Name / Activity |
|---|---|
| 5715 | (±)-ADX 71743 |
| Negative allosteric modulator of mGlu7 receptors; brain penetrant | |
| 2963 | MMPIP hydrochloride |
| Potent and selective negative allosteric modulator of mGlu7 receptors | |
| 1212 | MPEP hydrochloride |
| Positive allosteric modulator of mGlu4 receptors; also potent mGlu5 antagonist | |
| 5378 | VU 0422288 |
| Selective positive allosteric modulator of group III mGlu receptors | |
| 6893 | VU 6005649 |
| Positive allosteric modulators of mGlu7 and mGlu8 receptors; also NK1 antagonist; brain penetrant |
Our Pain guide highlights over 280 products for Pain research.
Request copyRequest PDF
Our Metabotropic Glutamate Receptor review gives an overview of the pharmacological ligands used to study the mGlu receptors.
Request copyRequest PDF
Written by Prof David Nutt, this poster summarizes the brain circuits and neurotransmitter systems that are affected by the main classes of addictive drugs.
Request copyDownload PDF
Written by Alsa Pitkänen and Xavier Ekolle Ndode-Ekane, this poster summarizes current knowledge about how epilepsy develops.
Request copyDownload PDFWritten by Clea Warburton and Zafar Bashir
Our Learning and Memory poster gives an overview of the cellular mechanisms underlying recognition memory and its links to long-term depression.
Request copyDownload PDFWritten by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDFWritten by Justin M. Saunders and Javier González-Maeso
Our Schizophrenia poster highlights the targets and pathways representing the most promising strategies to pursue for novel drug development.
Request copyDownload PDF